Myth: If You Feel Fine, the Treatment Isn't Working
No. Feeling completely normal on immunotherapy does not mean it has stopped working — and feeling unwell does not mean it's succeeding either. Checkpoint inhibitors work by releasing brakes on your own immune system rather than poisoning fast-dividing cells, so many patients feel fine while treatment is actively doing its job.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist · MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- No symptoms isn't a red flag — feeling normal is a common, expected experience on checkpoint inhibitors, not a warning sign
- Side effects aren't a report card — immune-related side effects can appear whether or not the treatment is working, and their absence says nothing either way
- Scans and tests tell the real story — imaging and, where relevant, tumour marker blood tests are what actually show whether your treatment is working
- Stopping on a feeling can cost you — abandoning a working treatment because you feel fine risks letting a responding cancer progress
on Panel
Survival Rate*
Treated
(800+ reviews)
If I feel fine on immunotherapy, does that mean it isn't working?
No. Feeling completely normal on immunotherapy is common and does not mean the treatment has stopped working. Checkpoint inhibitors help your own immune system act against cancer cells; unlike chemotherapy, they don't rely on making you feel unwell, so many patients feel fine even while the treatment is doing its job.
This myth is persuasive because it borrows logic from chemotherapy, where nausea, hair loss and fatigue can feel like visible proof that a powerful drug is circulating in the body. Immunotherapy works through an entirely different mechanism — it releases the brakes your immune system's own checkpoint proteins place on it, rather than poisoning cells directly — so the presence or absence of symptoms tells you very little about whether it is working.
Some patients do experience side effects, called immune-related adverse events (irAEs), when the reactivated immune system also affects healthy tissue. But an irAE is a sign the immune system has been switched on, not proof that it is successfully targeting the tumour. Plenty of patients with strong, lasting responses report barely noticing they are on treatment at all.
Did you know?
In published trials of checkpoint inhibitors, patients who experienced zero immune-related side effects have still achieved a durable tumour response — oncology teams track side effects and response as two completely separate measurements. (Source: NCCN and ASCO immunotherapy monitoring guidance, 2024.)
Do side effects indicate whether immunotherapy is working?
No — side effects and treatment response are assessed completely separately. A side effect shows your immune system has become more active somewhere in the body; a response is shown only by scans and tests measuring the tumour itself. Neither having side effects nor being free of them predicts which way your results will go.
These patterns follow NCCN and ASCO guidance on immunotherapy monitoring. No scan or blood test can be replaced by how you feel day to day — use this table to understand the pattern, not to judge your own case.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Don't guess — get it checked properly
Feeling fine or unwell is not a diagnosis. Talk to a CION oncology team member about how your specific response is actually being tracked.
Where does the "feeling fine means it isn't working" myth come from?
This idea persists because it borrows assumptions from chemotherapy and everyday illness, where feeling worse usually signals something is happening. Four patterns explain why it spreads so easily.
Suffering equals working
Patients and families who've seen chemotherapy assume any effective cancer treatment must come with visible side effects — immunotherapy often breaks that pattern.
"No pain, no gain" thinking
Outside of cancer care, feeling worse before feeling better is a familiar pattern — a hard workout, a strong medicine — that doesn't transfer the same way to this treatment.
Waiting feels unbearable
Between scans, patients naturally look for daily signs of progress; feeling fine can feel like an absence of evidence, even though it isn't evidence of failure.
One person's experience generalised
A forum post describing severe side effects alongside a good outcome gets remembered, while the many patients who felt fine and also did well go unmentioned.
How is response to immunotherapy actually measured?
Response is measured on a fixed schedule using CT or PET-CT imaging, physical exams, and for some cancers, tumour marker blood tests — never by daily symptoms. Your oncology team compares each scan against your baseline images to see whether the tumour has shrunk, stayed stable, or grown, and adjusts the plan accordingly.
- Baseline imaging — a CT or PET-CT scan taken before treatment starts, used as the comparison point for everything that follows.
- Scheduled follow-up scans — typically every 8 to 12 weeks, though your oncologist sets the exact interval for your case. PET-CT scans are coordinated through partner imaging centres, not performed in-house.
- Tumour marker blood tests — used where a relevant marker exists for your cancer, tracked as a trend over several visits rather than as one result.
- Physical examination and symptom review — done at every visit, but interpreted alongside scans, never as a stand-alone verdict.
- Your oncologist's overall assessment — the only person who can combine all of this into a real answer for your specific case.
None of these depend on how you feel between appointments. If you're ever unsure whether you're due for a scan, or anxious about what one might show, that's a reasonable question to bring to your care team directly — a far more reliable source of clarity than symptoms alone.
Before you consider stopping treatment
Never stop or skip immunotherapy doses because you feel fine, without your oncology team's involvement. Stopping a treatment that is genuinely working can allow the cancer to progress again. If cost, side effects, or scheduling are making treatment difficult, say so openly — that's a conversation to have with your oncologist, not a decision to make alone based on a feeling.
Correcting the wider "am I sure this is working" worry
- Myth: Once You Start, You Can Never Stop — another belief that pushes patients toward decisions based on assumption rather than their actual scans and results.
- Myth: Immunotherapy Is Only for the Rich — a separate misconception worth clearing up if cost concerns are part of why you're questioning your treatment.
- Miracle Cure Stories on Social Media: How to Read Them — the isolated success stories behind this myth deserve the same careful reading as any other online health claim.
- Immunotherapy at CION Cancer Clinics — the full picture of how CION supports patients through immunotherapy, from candidacy to response monitoring.
This page is for general information and does not replace a consultation. If you're unsure whether your immunotherapy is working, discuss your specific scans and reports directly with your oncology team.
Thousands of families have asked us this same question
Understanding how response is actually confirmed is the first step to feeling confident about your own treatment.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.